report-image

Cancer Biomarkers Market Analysis by Cancer Type(Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer), Based by Biomarker Type(Genetic biomarkers, Protein biomarkers), Based by Application(Drug discovery and development, Personalised medicine, Diagnostics), Based by Profiling Technology(Imaging technologies, Omic Technologies -Proteomics, Genomics, and Other Omic technologies, Cytogenetics-Based Tests, Immunoassays) and by Region: Global Forecast, 2024 - 2034

  • PUBLISHED ON
  • 2024-02-08
  • NO OF PAGES
  • 231
  • CATEGORY
  • Healthcare & Life Sciences

Market Overview

The Cancer Biomarkers market is predicted to develop at a compound annual growth rate (CAGR) of 12.4% from 2024 to 2034, when it is projected to reach USD 84.43 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 26.23 Billion in 2024.


SOURCE: We Market Research

Cancer biomarkers are chemicals or genetic changes that indicate the existence of cancer, its progression, or therapy response. They may be proteins, DNA, or other compounds found in blood, tissue, or bodily fluids. Biomarkers help with early cancer identification, prognosis, and monitoring. PSA is used to detect prostate cancer, whereas BRCA mutations are used to diagnose breast cancer. Biomarkers are important in personalised medicine because they predict therapy efficacy and indicate possible pharmacological targets. They play an important part in the advancement of precision oncology, with the goal of improving patient outcomes through personalised medicines based on individual biomarkers.

The Cancer Biomarkers Market is driven by rising cancer incidence worldwide, which necessitate better diagnosis technologies. Innovations in genomes, proteomics, and metabolomics improve biomarker discovery and validation. Biomarkers enable personalised medicine, which tailors therapies for greater efficacy and fewer negative effects. Government funding and supportive policies bolster R&D initiatives. Growing awareness among patients and healthcare providers about the benefits of early detection and tailored therapy fuels market growth. These variables work together to accelerate the development and application of cancer biomarkers, revolutionising cancer diagnosis, prognosis, and treatment options around the world. 

Market Scope

Report Attributes

Description

Market Size in 2024

USD 26.23 Billion

Market Forecast in 2034

USD 84.43 Billion

CAGR % 2024-2034

12.4%

Base Year

2023

Historic Data

2016-2022

Forecast Period

2024-2034

Report USP

 

Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

by Cancer Type, by Biomarker Type, by Application, by Profiling Technology and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria

 

Cancer Biomarkers Industry: Dynamics & Restrains


 Market opportunity:


 

 We Market Research: Cancer Biomarkers Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.


Cancer Biomarkers Segmentation

Market- By Cancer Type Analysis

By Cancer Type, the Cancer Biomarkers Market is Categories into Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Blood Cancer, Melanoma, Ovarian Cancer, Liver Cancer, Stomach Cancer. The Breast Cancer segment accounts for the largest share of around 38% in 2024.


Breast cancer biomarker market drivers include increasing incidence rates, a need for early detection, advances in genetic research, personalised medicine trends, and supportive healthcare policies that encourage biomarker development and implementation.

The following segments are part of an in-depth analysis of the global Cancer Biomarkers market:

Market Segments

 

by Biomarker Type

·         Genetic biomarkers

·         Protein biomarkers

by Application

·         Drug discovery and development

·         Personalised medicine

·         Diagnostics

by Profiling Technology

·         Imaging technologies

·         Omic Technologies -Proteomics

·         Genomics, and Other Omic technologies

·         Cytogenetics-Based Tests

·         Immunoassays

 

 Cancer Biomarkers Industry: Regional Analysis

North America Market Forecast

North America dominate the Cancer Biomarkers Market with the highest revenue generating market with share of more than 46%. The Cancer Biomarkers market in North America thrives due to the advanced healthcare infrastructure, high investment in research and development, and a strong presence of key market players. The United States, in particular, leads in biomarker research and adoption.


Europe Market Statistics

Europe's Cancer Biomarkers market benefits from the rising incidence of cancer in Europe increases demand for Cancer Biomarkers. Also, Benefits from robust healthcare policies driving demand for biomarkers and personalized medicine. Countries like Germany, France, and the UK are pivotal in advancing biomarker technologies and integrating them into clinical practice.

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Cancer Biomarkers market during the forecast period. In the Asia Pacific region, experiencing rapid growth with rising healthcare expenditure, escalating cancer rates, and improved healthcare infrastructure. Nations such as China, India, and Japan are at the forefront, expanding biomarker adoption to enhance early detection and personalized treatment strategies for cancer patients.

Key Market Players

The Cancer Biomarkers Market is dominated by a few large companies, such as

·         F. Hoffmann-La Roche Ltd.

·         Abbott

·         Thermo Fisher Scientific

·         Bio-Rad Laboratories, Inc.

·         CENTOGENE N.V.

·         Axon Medchem

·         Sino Biological Inc.

·         R&D System

·         BioVision Inc.

·         Myriad RBM 

·         Other

1.      Global Cancer Biomarkers Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Cancer Biomarkers Market Scope and Market Estimation

1.2.1. Global Cancer Biomarkers Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Cancer Biomarkers Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Cancer Type of Global Cancer Biomarkers Market

1.3.2. Biomarker Type of Global Cancer Biomarkers Market

1.3.3. Application of Global Cancer Biomarkers Market

1.3.4. Profiling Technologyof Global Cancer Biomarkers Market

1.3.5. Region of Global Cancer Biomarkers Market

2.      Executive Summary

2.1.    Global Cancer Biomarkers Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Cancer Biomarkers Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Cancer Biomarkers Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Cancer Biomarkers Market Estimates & Forecast Trend Analysis, by Cancer Type

4.1.    Global Cancer Biomarkers Market Revenue (US$ Mn) Estimates and Forecasts, by Cancer Type, 2019 to 2034

4.1.1. Breast Cancer

4.1.2. Lung Cancer

4.1.3. Prostate Cancer

4.1.4. Colorectal Cancer

4.1.5. Blood Cancer

4.1.6. Melanoma

4.1.7. Ovarian Cancer

4.1.8. Liver Cancer

4.1.9. Stomach Cancer

5.      Global Cancer Biomarkers Market Estimates & Forecast Trend Analysis, by Biomarker Type

5.1.    Global Cancer Biomarkers Market Revenue (US$ Mn) Estimates and Forecasts, by Biomarker Type, 2019 to 2034

5.1.1. Genetic biomarkers

5.1.2. Protein biomarkers

6.      Global Cancer Biomarkers Market Estimates & Forecast Trend Analysis, by Application

6.1.    Global Cancer Biomarkers Market Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034

6.1.1. Drug discovery and development

6.1.2. Personalised medicine

6.1.3. Diagnostics

7.      Global Cancer Biomarkers Market Estimates & Forecast Trend Analysis, by Profiling Technology

7.1.    Global Cancer Biomarkers Market Revenue (US$ Mn) Estimates and Forecasts, by Profiling Technology, 2019 to 2034

7.1.1. Imaging technologies

7.1.2. Omic Technologies -Proteomics

7.1.3. Genomics, and Other Omic technologies

7.1.4. Cytogenetics-Based Tests

7.1.5. Immunoassays

8.      Global Cancer Biomarkers Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Cancer Biomarkers Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Cancer Biomarkers Market: Estimates & Forecast Trend Analysis

9.1.    North America Cancer Biomarkers Market Assessments & Key Findings

9.1.1. North America Cancer Biomarkers Market Introduction

9.1.2. North America Cancer Biomarkers Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

9.1.2.1.   By Cancer Type

9.1.2.2.   By Biomarker Type

9.1.2.3.   By Application

9.1.2.4.   By Profiling Technology

9.1.2.5.   By Country

9.1.2.5.1.     The U.S.

9.1.2.5.2.     Canada

9.1.2.5.3.     Mexico

10.  Europe Cancer Biomarkers Market: Estimates & Forecast Trend Analysis

10.1.  Europe Cancer Biomarkers Market Assessments & Key Findings

10.1.1.   Europe Cancer Biomarkers Market Introduction

10.1.2.   Europe Cancer Biomarkers Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

10.1.2.1.    By Cancer Type

10.1.2.2.    By Biomarker Type

10.1.2.3.    By Application

10.1.2.4.    By Profiling Technology

10.1.2.5.    By Country

10.1.2.5.1. Germany

10.1.2.5.2. U.K.

10.1.2.5.3. France

10.1.2.5.4. Italy

10.1.2.5.5. Spain

10.1.2.5.6. Russia

10.1.2.5.7. Rest of Europe

11.  Asia Pacific Cancer Biomarkers Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Cancer Biomarkers Market Introduction

11.1.2.   Asia Pacific Cancer Biomarkers Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

11.1.2.1.    By Cancer Type

11.1.2.2.    By Biomarker Type

11.1.2.3.    By Application

11.1.2.4.    By Profiling Technology

11.1.2.5.    By Country

11.1.2.5.1. China

11.1.2.5.2. Japan

11.1.2.5.3. India

11.1.2.5.4. Australia

11.1.2.5.5. South Korea

11.1.2.5.6. ASEAN

11.1.2.5.7. Rest of Asia Pacific

12.  Middle East & Africa Cancer Biomarkers Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Cancer Biomarkers Market Introduction

12.1.2.   Middle East & Africa Cancer Biomarkers Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

12.1.2.1.    By Cancer Type

12.1.2.2.    By Biomarker Type

12.1.2.3.    By Application

12.1.2.4.    By Profiling Technology

12.1.2.5.    By Country

12.1.2.5.1. U.A.E.

12.1.2.5.2. Saudi Arabia

12.1.2.5.3. Egypt

12.1.2.5.4. South Africa

12.1.2.5.5. Rest of Middle East & Africa

13.  South America Cancer Biomarkers Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Cancer Biomarkers Market Introduction

13.1.2.   South America Cancer Biomarkers Market Size Estimates and Forecast (US$ Million) (2019 – 2034)

13.1.2.1.    By Cancer Type

13.1.2.2.    By Biomarker Type

13.1.2.3.    By Application

13.1.2.4.    By Profiling Technology

13.1.2.5.    By Country

13.1.2.5.1. Brazil

13.1.2.5.2. Argentina

13.1.2.5.3. Colombia

13.1.2.5.4. Rest of South America

14.  Competition Landscape

14.1.  Global Cancer Biomarkers Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Cancer Biomarkers Market Competition White Space Analysis, By End-user

14.3.  Global Cancer Biomarkers Market Competition Heat Map Analysis, By End-user

14.4.  Global Cancer Biomarkers Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     F. Hoffmann-La Roche AG.

15.1.1.   Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

15.2.      Abbott

15.3.      Thermo Fisher Scientific

15.4.      Bio-Rad Laboratories, Inc.

15.5.      CENTOGENE N.V.

15.6.      Axon Medchem

15.7.      Sino Biological Inc.

15.8.      R&D System

15.9.      BioVision Inc.

15.10.  Myriad RBM

15.11.  Other

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Cancer Biomarkers Market in 2024?

Cancer Biomarkers Market was valued at USD 26.23 Billion in 2024.

What is the growth rate for the Cancer Biomarkers Market?

Cancer Biomarkers Market size will increase at approximate CAGR of 12.4% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Cancer Biomarkers Market Are F. Hoffmann-La Roche Ltd., Abbott, Thermo Fisher Scientific, Bio-Rad Laboratories, Inc., CENTOGENE N.V., Axon Medchem, Sino Biological Inc., R&D System, BioVision Inc., Myriad RBM and Other.

Which region dominates the Cancer Biomarkers Market?

North America dominates the market with an active share of 46%.

Sample Request Customized Requirement Speak to Analyst Check Discount
CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3499

Only Three Thousand Four Hundred Ninety Nine US dollar

Buy Now
  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4499

Only Four Thousand Four Hundred Ninety Nine US dollar

Buy Now
  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5499

Only Five Thousand Four Hundred Ninety Nine US dollar

Buy Now
  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI